In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics
Columbia University · with University of California, Los Angeles, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT07296107
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 360
- US sites recruiting
- 1
- Study start
- May 8, 2026
- Record last updated
- July 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study examines how maternal stress during pregnancy affects infant brain and behavioral development, focusing on whether these effects are due to the prenatal environment or shared genes. By comparing IVF pregnancies using donor eggs/embryos (no shared genetics) with non-donor IVF pregnancies, the investigators aim to understand how stress influences the baby's development independent of genetic factors.
Participants will complete questionnaires, provide blood samples, and take part in placenta and cord blood collection, fetal monitoring, and newborn brain activity assessments.
Aim 1: The influence of maternal distress on perinatal neurobehavioral development.
Hypotheses: Independent of IVF group status, higher maternal AL will be associated with higher 3rd trimester FHR reactivity, lower FHR variability, AND lower FHR-movement coupling
Aim 2: Maternal distress affecting placenta gene methylation.
Hypotheses: Independent of IVF group status, maternal AL will be associated with placenta differential DNA methylation in glucocorticoid-regulating genes (FKBP5 and HSD11B2),
Aim 3: Maternal experiences associated with unique placenta transcriptomic profiles.
Hypotheses: Independent of IVF group status, maternal AL and well-being each will be associated with unique placenta gene expression in pro-inflammatory genes
Being studied: Prenatal maternal psychosocial and biological assessment protocol
Conditions: Maternal Distress; Child Development
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals at 18-28 gestational weeks with donor and homologous IVF pregnancies, ages 18-50.
- Participants must be patients receiving their perinatal health care through Columbia University Irving Medical Center's Department of OB/GYN and delivering at New York-Presbyterian Morgan Stanley Children's Hospital.
- Participants must be patients delivering at Columbia University Irving Medical Center's Department of OB/GYN and delivering at New York-Presbyterian Morgan Stanley Children's Hospital.
- Participants will include the offspring of patients receiving care and delivering at the above institutions.
- Enrollment Location(s): Columbia University Irving Medical Center's Department of OB/GYN, delivering at New York-Presbyterian Morgan Stanley Children's Hospital.
Exclusion Criteria
- Identified addiction disorder
- Severe psychiatric condition (defined as symptoms that significantly impair daily functioning and are untreated or not effectively managed)
- Multiple fetal pregnancy
- Known chromosomal, genetic, or major fetal malformations (unlikely due to routine preimplantation genetic testing)
- Inflammatory conditions including rheumatoid arthritis, lupus, and multiple sclerosis
- Not planning to deliver at a CUIMC-affiliated hospital
Recruiting US locations
Columbia University Irving Medical Center/New York Presbyterian Hospital
New York, NY 10032
Site contact: Khadija Jones, MPH · 917-817-1490 · kj2660@cumc.columbia.edu
Study contacts (from the official record)
- Catherine Monk, PhD · 917-543-6031 · cem31@cumc.columbia.edu
- Khadija Jones, MPH · 917-817-1490 · kj2660@cumc.columbia.edu
Similar studies in New York
All pregnancy studies in New York →- RecruitingHealthy volunteersEarly Phase 1
Predictors of Aspirin Failure in Preeclampsia Prevention
Rockefeller University
- Location
- New York, NY
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteers
Integration of the Oura Ring and Maven Clinic Among Women Who Are Trying to Conceive
Ouraring Inc.
- Location
- New York, NY
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Flushing, NY + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
A Study to Learn About the Safety of PENBRAYA During Pregnancy
Pfizer
- Location
- New York, NY
- Eligibility basics
- Ages 10–25 · Women only